emery taylor

  • 97

    97. That’s my latest CD4+ count, less than half the count from six weeks ago.

    That’s it. I have tried as many alternative treatments as I can think of to reverse the decline. I will be starting my third round of pharmaceutical ARVs as soon as I can get a prescription and fill it.

    This decision has been a long time coming, and in hindsight, I probably should have restarted a few months ago. There’s nothing magical about 97, or being below 100, but it’s as good a breaking point as any. I’ve long argued that there are two things to keep in mind about CD4 counts: one is the long-term trend; the other is single- or low double-digit counts.

  • Who needs t-cells, anyway?

    There seems to be a natural tendency among some skeptics and questioners that when part of a theory or concept is proven to be flawed, any and all other aspects about it should be dismissed as well.

    This certainly seems to be the case for some AIDS dissidents when it comes to discussions about the significance of certain laboratory markers, in particularly certain immune cells involved in fighting infections, called CD4 t-cells. CD4 counts are, arguably, considered by mainstream AIDS experts as the single most important measure of disease progression and risk for patients acquiring opportunistic infections.

  • A link I never expected – UPDATED

    Tim Horn, an Administrator and paid staff member of the AIDSmeds forums, recently gave me a compliment.  I think.  Horn posted a thread at those forums, acknowledging the transition of Emery Taylor, which I reported on a few weeks ago. Horn called this blog “one clear-eyed ‘alternative hypothesis’ site”, and I appreciate that.  Really,…